• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Radiol . Diagnostic accuracy and interobserver variability of CO-RADS in patients with suspected coronavirus disease-2019: a multireader valida

tetano

Editor, Senior Moderator
Eur Radiol


. 2020 Sep 23.
doi: 10.1007/s00330-020-07273-y. Online ahead of print.
Diagnostic accuracy and interobserver variability of CO-RADS in patients with suspected coronavirus disease-2019: a multireader validation study


Davide Bellini[SUP] 1 2 [/SUP], Nicola Panvini[SUP] 3 [/SUP], Marco Rengo[SUP] 3 [/SUP], Simone Vicini[SUP] 3 [/SUP], Miriam Lichtner[SUP] 4 [/SUP], Tiziana Tieghi[SUP] 4 [/SUP], Dea Ippoliti[SUP] 3 [/SUP], Federica Giulio[SUP] 3 [/SUP], Elena Orlando[SUP] 3 [/SUP], Mario Iozzino[SUP] 5 [/SUP], Maria Grazia Ciolfi[SUP] 5 [/SUP], Sarah Montechiarello[SUP] 5 [/SUP], Ugo d'Ambrosio[SUP] 5 [/SUP], Emanuele d'Adamo[SUP] 5 [/SUP], Chiara Gambaretto[SUP] 5 [/SUP], Stefano Panno[SUP] 5 [/SUP], Vanessa Caldon[SUP] 5 [/SUP], Cesare Ambrogi[SUP] 5 [/SUP], Iacopo Carbone[SUP] 3 [/SUP]



Affiliations

Abstract

Objective: To conduct a multireader validation study to evaluate the interobserver variability and the diagnostic accuracy for the lung involvement by COVID-19 of COVID-19 Reporting and Data System (CO-RADS) score.
Methods: This retrospective study included consecutive symptomatic patients who underwent chest CT and reverse transcriptase-polymerase chain reaction (RT-PCR) from March 2020 to May 2020 for suspected COVID-19. Twelve readers with different levels of expertise independently scored each CT using the CO-RADS scheme for detecting pulmonary involvement by COVID-19. Receiver operating characteristic (ROC) curves were computed to investigate diagnostic yield. Fleiss' kappa statistics was used to evaluate interreader agreement.
Results: A total of 572 patients (mean age, 63 ? 20 [standard deviation]; 329 men; 142 patients with COVID-19 and 430 patients without COVID-19) were evaluated. There was a moderate agreement for CO-RADS rating among all readers (Fleiss' K = 0.43 [95% CI 0.42-0.44]) with a substantial agreement for CO-RADS 1 category (Fleiss' K = 0.61 [95% CI 0.60-0.62]) and moderate agreement for CO-RADS 5 category (Fleiss' K = 0.60 [95% CI 0.58-0.61]). ROC analysis showed the CO-RADS score ≥ 4 as the optimal threshold, with a cumulative area under the curve of 0.72 (95% CI 66-78%), sensitivity 61% (95% CI 52-69%), and specificity 81% (95% CI 77-84%).
Conclusion: CO-RADS showed high diagnostic accuracy and moderate interrater agreement across readers with different levels of expertise. Specificity is higher than previously thought and that could lead to reconsider the role of CT in this clinical setting.
Key points: • COVID-19 Reporting and Data System (CO-RADS) demonstrated a good diagnostic accuracy for lung involvement by COVID-19 with an average AUC of 0.72 (95% CI 67-75%). • When a threshold of ≥ 4 was used, sensitivity and specificity were 61% (95% CI 52-69%) and 81% (95% CI 76-84%), respectively. • There was an overall moderate agreement for CO-RADS rating across readers with different levels of expertise (Fleiss' K = 0.43 [95% CI 0.42-0.44]).

Keywords: COVID-19; ROC curve; Sensitivity and specificity; Severe acute respiratory syndrome coronavirus 2; Tomography, X-ray computed.
 
Back
Top Bottom